ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 660 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Lurbinectedin Zongertinib Shows Durable Antitumour Activity in First-Line Treatment for Patients with Previously Untreated HER2-mutated Advanced NSCLC Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian MOST POPULAR Black In Cancer – That Cancer Conversation October 8, 2021 New Research in Treating Non-Hodgkin Lymphoma and Predicting the Risk of... January 26, 2023 Alzheimer’s-Linked Protein May Help Melanoma Spread to Brain April 1, 2022 Hero Nanny Permanently Injured While Saving 2-Year-Old From Speeding Car About... March 5, 2019 Load more HOT NEWS Breakthrough SARS-CoV-2 Infection Following COVID-19 Vaccination in Patients with Cancer Toddler Celebrates 11 Months Cancer-Free In Adorable Dance Video With Dad. How Alcohol Increases Your Cancer Risk and What to Know About... Cancer services during COVID-19: 40,000 fewer people starting treatment
